Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP3K5 | Q99683 | 17/20 | 0.40 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.34 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.34 |
| ▸ | PIK3C3 | Q8NEB9 | 1/20 | 0.33 |
| ▸ | MYLK | Q15746 | 1/20 | 0.31 |
| ▸ | AKT1 | P31749 | 4/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22739076 | 0.82 | MAP3K5 (0.40) | MAP3K5AKT1 | |
| SCHEMBL22738967 | 0.80 | MAP3K5 (0.45) | MAP3K5MYLK | |
| SCHEMBL947535 | 0.80 | MAP3K5 (0.60) | MAP3K5 | |
| SCHEMBL22738980 | 0.71 | MAP3K5 (0.41) | MAP3K5AKT1 | |
| SCHEMBL946344 | 0.69 | MAP3K5 (0.57) | MAP3K5 | |
| SCHEMBL22738975 | 0.69 | MAP3K5 (0.42) | MAP3K5MYLKAKT1 | |
| SCHEMBL945480 | 0.69 | MAP3K5 (0.62) | MAP3K5MYLK | |
| SCHEMBL22739190 | 0.69 | MAP3K5 (0.39) | MAP3K5AKT1 | |
| SCHEMBL945351 | 0.68 | MAP3K5 (0.62) | MAP3K5MYLK | |
| SCHEMBL946361 | 0.68 | MAP3K5 (0.53) | MAP3K5MYLK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3858824-A1 | APOPTOSIS SIGNAL-REGULATING KINASE INHIBITORS | Gilead Sciences, Inc. (US) | 2021-08-04 | — | — | EP | disclosed |